Welcome to LookChem.com Sign In|Join Free
  • or
Mosloflavone, a flavonoid compound, is found in various plants such as St. John's wort and Siegesbeckia orientalis. It exhibits multiple biological activities, including anti-inflammatory, antioxidant, and anti-cancer properties. Its ability to inhibit the growth of certain cancer cells, reduce inflammation, and provide protective effects on the liver and cardiovascular system makes it a promising natural compound for further research and development in various therapeutic applications.

740-33-0

Post Buying Request

740-33-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

740-33-0 Usage

Uses

Used in Pharmaceutical Industry:
Mosloflavone is used as an anti-inflammatory agent for its ability to reduce inflammation in experimental models. Its anti-inflammatory properties make it a potential candidate for the treatment of inflammatory diseases.
Used in Anticancer Applications:
Mosloflavone is used as an anti-cancer agent, particularly for its ability to inhibit the growth of certain cancer cells. It has shown potential in the treatment of various types of cancer, making it a promising compound for further research and development in oncology.
Used in Cardiovascular Health:
Mosloflavone is used as a protective agent for the cardiovascular system due to its antioxidant properties. Its potential to protect the heart and blood vessels from oxidative stress and inflammation makes it a valuable compound for the prevention and treatment of cardiovascular diseases.
Used in Liver Health:
Mosloflavone is used as a hepatoprotective agent for its protective effects on the liver. Its ability to support liver function and protect against liver damage makes it a promising compound for the prevention and treatment of liver-related disorders.

Check Digit Verification of cas no

The CAS Registry Mumber 740-33-0 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 7,4 and 0 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 740-33:
(5*7)+(4*4)+(3*0)+(2*3)+(1*3)=60
60 % 10 = 0
So 740-33-0 is a valid CAS Registry Number.
InChI:InChI=1/C17H14O5/c1-20-14-9-13-15(16(19)17(14)21-2)11(18)8-12(22-13)10-6-4-3-5-7-10/h3-9,19H,1-2H3

740-33-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-Hydroxy-6,7-dimethoxy-2-phenyl-4H-chromen-4-one

1.2 Other means of identification

Product number -
Other names 5-hydroxy-6,7-dimethoxy-2-phenylchromen-4-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:740-33-0 SDS

740-33-0Relevant academic research and scientific papers

An unambiguous and practical synthesis of Oroxylin A: a commonly misidentified flavone

Hemantha, Hosahalli P.,Ramanujam, Rajendran,Majeed, Muhammed,Nagabhushanam, Kalyanam

, p. 1413 - 1420 (2019/08/22)

Oroxylin A, a major flavonoid in the extracts of Oroxylum indicum as well as Scutellaria baicalensis possesses useful medicinal properties. Many of the published routes claiming the synthesis of Oroxylin A (1) have in fact led to a regioisomer Negletein that was misinterpreted as Oroxylin A. In the present work, we describe a novel, straight-forward and scalable semi-synthetic approach for rapid access to the title compound, the structure of which is unambiguously secured by NMR and X-ray crystallographic analysis of a derivative. This work also encompasses the synthesis of a glycosylated derivative of Oroxylin A viz OAGME (2), which has marked pharmacological importance.

PROCESS FOR SYNTHESIS OF OROXYLIN A

-

Page/Page column 7-9, (2020/03/02)

Disclosed is a novel, simple, scalable and environment friendly process for the synthesis of Oroxylin A from Baicalin. Baicalm is esterified to obtain a methyl ester which is further selectively methylated to provide Oroxylin A gluciironide methyl ester w

Process for synthesis of Oroxylin A

-

Page/Page column 4; 7; 8, (2019/09/23)

Disclosed is a novel, simple, scalable and environment friendly process for the synthesis of Oroxylin A from Baicalin. Baicalin is esterified to obtain a methyl ester which is further selectively methylated to provide Oroxylin A glucuronide methyl ester which on de-glycosylation results in the formation of Oroxylin A.

Role of some food-grade synthesized flavonoids on the control of ochratoxin a in aspergillus carbonarius

Ricelli, Alessandra,De Angelis, Martina,Primitivo, Ludovica,Righi, Giuliana,Sappino, Carla,Antonioletti, Roberto

, (2019/07/18)

Ochratoxin A (OTA) is a mycotoxin with a serious impact on human health. In Mediterranean countries, the black Aspergilli group, in particular Aspergillus carbonarius, causes the highest OTA contamination. Here we describe the synthesis of three polyphenolic flavonoids: 5-hydroxy-6,7-dimethoxy-flavone (MOS), 5,6-dihydroxy-7-methoxy-flavone (NEG), and 5,6 dihydroxy-flavone (DHF), as well as their effect on the prevention of OTA biosynthesis and lipoxygenase (LOX) activity in A. carbonarius cultured in a conducive liquid medium. The best control effect on OTA biosynthesis was achieved using NEG and DHF. In fungal cultures treated with these compounds at 5, 25, and 50 μg/mL, OTA biosynthesis significantly decreased throughout the 8-day experiment. NEG and DHF appear to have an inhibiting effect also on the activity of LOX, whereas MOS, which did not significantly inhibit OTA production, had no effect on LOX activity. The presence of free hydroxyls in catecholic position in the molecule appears to be a determining factor for significantly inhibiting OTA biosynthesis. However, the presence of a methoxy group in C-7 in NEG could slightly lower the molecule’s reactivity increasing OTA inhibition by this molecule at 5 μg/mL. Polyphenolic flavonoids present in edible plants may be easily synthesized and used to control OTA biosynthesis.

New alkoxy flavone derivatives targeting caspases: Synthesis and antitumor activity evaluation

Moreira, Joana,Ribeiro, Diana,Silva, Patrícia M. A.,Nazareth, Nair,Monteiro, Madalena,Palmeira, Andreia,Saraiva, Lucília,Pinto, Madalena,Bousbaa, Hassan,Cidade, Honorina

, (2019/01/14)

The antitumor activity of natural flavonoids has been exhaustively reported. Previously it has been demonstrated that prenylation of flavonoids allows the discovery of new compounds with improved antitumor activity through the activation of caspase-7 activity. The synthesis of twenty-five flavonoids (4-28) with one or more alkyl side chains was carried out. The synthetic approach was based on the reaction with alkyl halide in alkaline medium by microwave (MW) irradiation. The in vitro cell growth inhibitory activity of synthesized compounds was investigated in three human tumor cell lines. Among the tested compounds, derivatives 6, 7, 9, 11, 13, 15, 17, and 18 revealed potent growth inhibitory activity (GI50 10 μM), being the growth inhibitory effect of compound 13 related with a pronounced caspase-7 activation on MCF-7 breast cancer cells and yeasts expressing human caspase-7. A quantitative structure-activity relationship (QSAR) model predicted that hydrophilicity, pattern of ring substitution/shape, and presence of partial negative charged atoms were the descriptors implied in the growth inhibitory effect of synthesized compounds. Docking studies on procaspase-7 allowed predicting the binding of compound 13 to the allosteric site of procaspase-7.

2-substituted benzopyran-4-one compounds and application thereof

-

Paragraph 0146; 0147; 0148; 0155; 0156; 0157, (2016/10/08)

The invention relates to the technical field of medicine and discloses 2-substituted benzopyran-4-one compounds with a structure shown in general formula I and an application of the compounds in preparation of antifungal drugs and synergistic antifungal drugs. The compounds can be jointly used with azole antifungal drugs, can improve sensibility of drug-resistance bacteria to the azole drugs, reverses drug resistance and produces a synergistic antifungal function.

Synthesis and evaluation of selenoflavones that have potential neuroprotective effects

Choi, Yong-Sung,Kim, Yoon-Jung,Lee, Ju Yeun,Lee, Jinu,Jeong, Jin-Hyun

, p. 2794 - 2805 (2015/03/04)

We synthesized selenoflavones and evaluated their physicochemical properties and antioxidant effects. When oxygen was substituted with selenium, the compounds exhibited improved polarity and lipophilicity, implying that this change could lead to better BBB penetration. Selenoflavones revealed more potent antioxidant activity in our in-vitro assay. This suggests that selenoflavones would be more druggable than flavones and have a better potential as a neuroprotective agent.

Synthesis of ring A-modified baicalein derivatives

Wang, Jun-Fei,Ding, Ning,Zhang, Wei,Wang, Peng,Li, Ying-Xia

experimental part, p. 2221 - 2230 (2012/01/14)

Baicalein, an important active constituent of the traditional Chinese herb Scutellaria baicalensis, exhibited antitumor activity and inhibitory activity against P-gp 170. The syntheses of 25 baicalein derivatives, 2-26 (Table), are described here (Scheme

Convergent synthesis of mosloflavone, negletein and baicalein from crysin

Righi, Giuliana,Antonioletti, Roberto,Silvestri, Ilaria Proietti,D'Antona, Nicola,Lambusta, Daniela,Bovicelli, Paolo

experimental part, p. 1294 - 1298 (2010/04/02)

An expeditious synthesis of three polyoxygenated flavones: mosloflavone, negletein and baicalein, starting from crysin, an easily available flavone, by a bromination/methoxylation procedure is reported. The convergent synthesis exploits a base induced Wesley-Moser type rearrangement.

COMPOUNDS AND METHODS TO INCREASE ANTI-P-GLYCOPROTEIN ACTIVITY OF BAICALEIN BY ALKYLATION ON THE A RING

-

Page/Page column 30, (2010/02/13)

The present invention is directed to analogs of baicalein according to formula (I): where R5 is H, (CI-C12)alkyl, (C2-C13)acyl, or an optionally substituted phenyl or benzyl group, an acyl group, a C1-C20 alkyl or ether group, a phosphate, diphosphate, triphosphate or phosphodiester group; R6 and R7 are each independently H, (C1-C12)alkyl, (C2-C13)acyl, or an optionally substituted phenyl or benzyl or together form a -OCR1R20- group wherein each of R1 and R2 is independently H, a C1-C3 alkyl group or an optionally substituted phenyl or benzyl group; and R8 is H, OH, an O-acyl group, a C1,-C4 alkyl or alkoxy group, F, Cl, Br or I, or a pharmaceutically acceptable salt thereof, which exhibit anti-P-glycoprotein activity and methods of enhancing the bioavailability of active compounds, especially orally administered compounds, by inhibition of P-glycoprotein 170 (P-gp 170) and/or CYP450 enzyme, especially CYP450 3A4 enzyme. Pharmaceutical compositions based upon these novel derivatives according to the present invention are also described herein.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 740-33-0